Meta-analysis of the expression characteristics and clinical significance of autophagy related protein Beclin1 in esophageal squamous cell carcinoma
FAN Xiangrong1 ZHAO Hang1 WU Hongyang1 XU Shaoqing1 FAN Huanfang2
1.Graduate School, Hebei University of Chinese Medicine, Hebei Province, Shijiazhuang 050091, China;
2.the Second Department of Oncology, the First Affiliated Hospital of Hebei University of Chinese Medicine, Hebei Province, Shijiazhuang 050011, China
Abstract：Objective To systematically evaluate the expression characteristics and clinical significance of autophagy related protein Beclin1 in esophageal squamous cell carcinoma (ESCC). Methods The literatures of expression characteristics of Beclin1 in ESCC and its relationship with clinicopathological features were searched by computer from the inception to December 2021 in PubMed, Web of Science, CNKI, Wanfang Data, and VIP. Meta-analysis was performed by RevMan 5.4. Results A total of 13 literatures were included, including 1 080 ESCC patients. The results of meta-analysis showed that Beclin1 expression in ESCC group was lower than that in control group (OR=0.09, 95%CI: 0.05-0.17, P＜0.000 01). Beclin1 expression in highly and moderately differentiated ESCC patients was higher than that in poorly differentiated ESCC patients (OR=2.01, 95%CI: 1.49-2.72, P＜0.000 01). Beclin1 expression in ESCC patients with TNM stage Ⅰ-Ⅱ was higher than that in patients with stage Ⅲ-Ⅳ (OR=2.78, 95%CI: 1.76-4.41, P＜0.000 1). Beclin1 expression in ESCC patients with infiltration depth from T1-T2 was higher than that in T3-T4 patients (OR=2.16, 95%CI: 1.58-2.97, P＜0.000 01). Beclin1 expression in ESCC patients without lymph node metastasis was higher than that in patients with lymph node metastasis (OR=0.26, 95%CI: 0.14-0.49, P＜0.000 1). Conclusion Beclin1 expression is closely related to the clinicopathological features of ESCC, and Beclin1 may be an important target involved in the occurrence and development of ESCC.
范向荣1 赵行1 武洪杨1 许绍青1 范焕芳2. 自噬相关蛋白Beclin1在食管鳞癌中表达特点及临床意义的meta分析[J]. 中国医药导报, 2023, 20(2): 97-100.
FAN Xiangrong1 ZHAO Hang1 WU Hongyang1 XU Shaoqing1 FAN Huanfang2. Meta-analysis of the expression characteristics and clinical significance of autophagy related protein Beclin1 in esophageal squamous cell carcinoma. 中国医药导报, 2023, 20(2): 97-100.
[1] Siegel RL，Miller KD，Fuchs HE，et al. Cancer Statistics，2021 [J]. CA Cancer J Clin，2021，71（1）：7-33.
[2] 陈茹，郑荣寿，张思维，等.2015年中国食管癌发病和死亡情况分析[J].中华预防医学杂志，2019（11）：1094-1097.
[3] Torre LA，Siegel RL，Ward EM，et al. Global cancer incidence and mortality rates and trends-an update [J]. Cancer Epidemiol Biomarkers Prev，2016，25（1）：16-27.
[4] Saxena R，Klochkova A，Murray MG，et al. Roles for Autophagy in Esophageal Carcinogenesis：Implications for Improving Patient Outcomes [J]. Cancers（Basel），2019，11（11）：1697.
[5] Buzun K，Gornowicz A，Lesyk R，et al. Autophagy Modulators in Cancer Therapy [J]. Int J Mol Sci，2021，22（11）：5804.
[6] Du H，Luo F，Shi M，et al. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell cancer Population [J]. Pathol Oncol Res，2021，27：594724.
[7] 杜海磊.自吞噬在食管癌发生发展中的作用及其体外调控化疗敏感性的机制研究[D].上海：上海交通大学，2019.
[8] Wu N，Zhu Y，Xu X，et al. The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell cancer [J]. J Cancer，2018，9（6）：987-997.
[9] Chen HI，Tsai HP，Chen YT，et al. Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell cancer [J]. Pathol Oncol Res，2016，22（4）：699-705.
[10] 金婷婷.自噬相关蛋白Beclin1和LC3在汉族和哈族食管癌中的表达及临床意义[D].石河子：石河子大学，2016.
[11] 吴娟.Beclin1在人食管鳞状细胞癌中的表达及与药物敏感性关系的实验研究[D].石家庄：河北医科大学，2013.
[12] Chen Y，Li X，Wu X，et al. Autophagy-related proteins LC3 and Beclin1 impact the efficacy of chemoradiation on esophageal squamous cell cancer [J]. Pathol Res Pract，2013， 209（9）：562-567.
[13] 夏彦清，赵松.Beclin1和LC3在食管癌组织中的表达水平和临床意义[J].中国老年学杂志，2012，32（5）：907- 909.
[14] 刘东雷.调整自噬表达对食管癌EC9706细胞化疗敏感性的影响及其机制研究[D].武汉：华中科技大学，2011.
[15] 宋海侠，陈永顺，王立帅，等.自噬基因Beclin1与凋亡基因Bax、Bcl-2在食管癌中的表达及意义[J].山东医药，2010，50（45）：29-30.
[16] 单国用，刘兴安，张松，等.食管鳞状细胞癌组织中自噬基因Beclin1蛋白的表达[J].郑州大学学报（医学版），2010，45（3）：366-368.
[17] Chen Y，Lu Y，Lu C，et al. Beclin1 expression is a predictor of clinical outcome in patients with esophageal squamous cell cancer and correlated to hypoxia-inducible factor（HIF）-1alpha expression [J]. Pathol Oncol Res，2009，15（3）：487-493.
[18] 卢瑞利，邵经浩，郭长青.自噬相关基因Beclin1和PTEN在食管癌中的表达和意义[J].临床荟萃，2009，24（18）：1586-1589.
[19] Kaur S，Changotra H. The Beclin1 interactome：Modification and roles in the pathology of autophagy-related disorders [J]. Biochimie，2020，175：34-49.
[20] 温明博，林嘉恒，刘志龙，等.ULK1和Beclin1在原发性肝细胞癌中的表达及临床意义[J].暨南大学学报（自然科学与医学版），2021，42（5）：463-469.
[21] 眭怡群，冯一中.自噬相关基因LC3、Beclin1与凋亡相关基因p53、BCL-2在大肠癌中的表达及意义[J].临床与实验病理学杂志，2012，28（3）：282-286.
[22] Zhang J，Dong W. Lentiviral-Mediated Beclin1 Overexpression Inhibits CellProliferation and Induces Autophagy of Human Esophageal cancer Eca109 CellXenograft in Nude Mice [J]. Recent Pat Anticancer Drug Discov，2020， 15（1）：70-77.
[23] 洪斌，吴庆琛，张诚，等.过表达Beclin1对食管癌Eca109细胞生物学行为的影响[J].重庆医科大学学报，2014，39（12）：1713-1718.
[24] 武冰洁.自噬相关蛋白Beclin-1在胃癌患者中表达意义的meta分析[D].太原：山西医科大学，2019.
[25] 赖人旭，麦蕾，高敏照，等.结肠癌组织中Beclin1、p62的表达及与临床病理特征的关系[J].中国老年学杂志，2017，37（20）：5059-5061.
[26] 刘军刚，刘洋，哈庆.miR-181c-5p靶向作用Beclin1抑制口腔鳞癌SCC-090细胞增殖并促进细胞凋亡的机制[J].河北医药，2021，43（18）：2734-2737
[27] 周京涛，刘佳，李亮，等.miRNA-216b通过靶向调控Beclin1对顺铂诱导的胃癌细胞自噬及凋亡的影响[J].中国中西医结合消化杂志，2021，29（6）：398-405.
京公网安备 11010502046598号